Home > Healthcare > Medical Devices > Medical Supplies > MRI Contrast Media Market

MRI Contrast Media Market Size

  • Report ID: GMI7600
  • Published Date: Dec 2023
  • Report Format: PDF

MRI Contrast Media Market Size

MRI Contrast Media Market size was valued USD 1.6 billion in 2023 and is expected to grow at a CAGR of 4.6% between 2024 and 2032. The market growth is driven by the growing prevalence of chronic diseases, rising demand for early diagnosis, and increased R&D investment and activities.<

 

As reported by the American Cancer Society projected figures for new cancer cases and deaths in 2022 indicate an estimated 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the U.S. alone. Thus, rise in cancer/oncology cases is expected to spur the demand for early diagnosis.
 

MRI contrast media, also known as contrast agents, are imaging agents or the substances injected to enhance the visibility of the tissues or organs during MRI procedure. These agents contain the magnetism properties that alter the magnetic resonance properties of surrounding tissues, providing clearer and more detailed images. MRI contrast media assist in visualizing and characterizing abnormalities like tumors, inflammation, and vascular conditions during MRI scans with enhanced diagnostic precision.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The hospitals segment is anticipated to record over 4.5% CAGR from 2023 to 2032 as these are primary facilities for patients undergoing major diagnostic tests, making MRI contrast media the focal point.

The extracellular contrast agents segment is expected to reach USD 1.9 billion by 2032 due to their efficacy in enhancing image contrast.

The hospitals segment is anticipated to record over 4.5% CAGR from 2023 to 2032 as these are primary facilities for patients undergoing major diagnostic tests, making MRI contrast media the focal point.

Bayer HealthCare LLC, Guerbet LLC, GE HealthCare, Lantheus Medical Imaging, Inc., B. Chemicals and Pharmaceuticals Ltd., Bracco, BioPAL, Inc., Vitalquan, LLC, Fresenius Kabi, and Polarean.

MRI Contrast Media Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 316
  • Countries covered: 19
  • Pages: 180
 Download Free Sample